» Articles » PMID: 30550756

Significance of Obstetrical History with Future Cardiovascular Disease Risk

Overview
Journal Am J Med
Specialty General Medicine
Date 2018 Dec 15
PMID 30550756
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The maternal cardiovascular system undergoes profound changes to support the increasing demands of fetal growth during pregnancy. An accumulating body of evidence has shown that common pregnancy complications, including gestational diabetes mellitus, preeclampsia, low birth weight, and preterm delivery, can be associated with future cardiovascular adverse events in mothers. Factors such as glucose metabolism, hyperlipidemia, inflammatory markers, and large- and small-vessel stiffness/functionality have been linked with these pregnancy conditions. Critically, there are no established guidelines to account for these maternal factors when considering future cardiovascular disease risk, one of the leading causes of female mortality. This article reviews the study of cardiovascular disease and pregnancy, and proposes possible connections that should spur future investigation in an area of medicine that requires significant research.

Citing Articles

Epigenetic drug screening for trophoblast syncytialization reveals a novel role for MLL1 in regulating fetoplacental growth.

Wu J, Qin C, Tian F, Liu X, Hu J, Wu F BMC Med. 2024; 22(1):57.

PMID: 38317232 PMC: 10845764. DOI: 10.1186/s12916-024-03264-8.


Serologic Status of sensu lato in Patients with Cardiovascular Changes.

Pietruszka K, Reagan F, Stazka J, Koziol M Int J Environ Res Public Health. 2023; 20(3).

PMID: 36767604 PMC: 9915009. DOI: 10.3390/ijerph20032239.


Temporal Trends in Adverse Pregnancy Outcomes in Birthing Individuals Aged 15 to 44 Years in the United States, 2007 to 2019.

Freaney P, Harrington K, Molsberry R, Perak A, Wang M, Grobman W J Am Heart Assoc. 2022; 11(11):e025050.

PMID: 35583146 PMC: 9238733. DOI: 10.1161/JAHA.121.025050.


Preeclampsia and Fetal Congenital Heart Defects.

Ferreira B, Barros T, Moleiro M, Guedes-Martins L Curr Cardiol Rev. 2022; 18(5):80-91.

PMID: 35430980 PMC: 9896419. DOI: 10.2174/1573403X18666220415150943.


Extravillous trophoblast migration and invasion: Impact of environmental chemicals and pharmaceuticals.

Meakin C, Barrett E, Aleksunes L Reprod Toxicol. 2021; 107:60-68.

PMID: 34838982 PMC: 8760155. DOI: 10.1016/j.reprotox.2021.11.008.